Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation

Fig. 1

Heatmap and survival analysis based on unsupervised hierarchical clustering, and status of JAK2/PD-L1 amplification and MYD88 mutation in TCGA dataset. a, Heatmap of CNA-based profiles of driver genes in DLBCL and PMBCL by using unsupervised hierarchical clustering. b, Survival curves and cox-regression analysis of OS and PFS among three CNA-based clusters after RCHOP-like treatment. c, Status of amplifications of JAK2, PD-L1(CD274) and PD-L2(PDCD1LG2), and mutation of MYD88 in DLBCL (TCGA, PanCancer Atlas) from cBioPortal [8, 9]

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us